A Pennsylvania state senator and former GOP gubernatorial candidate whose support for Donald Trump drew him to the U.S.
The FDA’s priority review voucher program for rare pediatric diseases is set to lapse on Sept. 30 without congressional intervention.
Chair Lina Khan’s aggressive stance on antitrust has been widely criticized by corporate America. But it’s also won her ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...